Restylane Refyne Regulatory Status: A Professional Sourcing Guide

Restylane Refyne is a hyaluronic acid (HA) dermal filler manufactured by Galderma, originating from Sweden. This product is formulated for specific aesthetic applications, designed to integrate smoothly into tissues. As a prominent HA filler, it forms part of a broader category of products clinics source for various aesthetic treatments. Professionals often compare such products with other established options available in the market for specific indications. You can explore a wider range of hyaluronic acid dermal filler catalog to understand market diversity.

Global regulatory bodies oversee the safety and efficacy of aesthetic injectables. Restylane Refyne holds several important certifications.

• FDA Approval (United States): Restylane Refyne is approved by the U.S. Food and Drug Administration (FDA) for the correction of moderate to severe facial wrinkles and folds.
• CE Mark (European Union): As a product manufactured in Sweden by Galderma, Restylane Refyne carries the CE Mark, indicating conformity with European health, safety, and environmental protection standards.
• KFDA (South Korea): [VERIFY: KFDA approval status for Restylane Refyne in South Korea]. Professionals should confirm local product registration status in specific APAC markets.
• GMP & ISO Standards: Galderma, as a major pharmaceutical company, operates under Good Manufacturing Practice (GMP) standards and often holds ISO certifications, ensuring quality management systems in manufacturing processes.

The legal availability of Restylane Refyne varies across international markets, influenced by local health authority registrations.

• European Union (EU) & United Kingdom (UK): The CE Mark facilitates market entry, making Restylane Refyne widely available, though specific national distribution agreements apply.
• GCC (Gulf Cooperation Council): Market access in countries like UAE, Saudi Arabia, and Qatar requires local Ministry of Health registration. Suppliers must provide evidence of this for legitimate import.
• LATAM (Latin America): Each country in Latin America, such as Brazil (ANVISA) or Mexico (COFEPRIS), has its own regulatory requirements for product importation and sale.
• APAC (Asia-Pacific): Beyond KFDA, other key markets like Australia (TGA), China (NMPA), and Japan (PMDA) have distinct regulatory pathways for dermal fillers. Professionals must verify local registration details for their specific country of operation.

Parallel imports refer to genuine products imported into a market outside the manufacturer's authorized distribution channels. While these products are authentic, they often lack official local market registration or support, potentially voiding warranties and making traceability difficult. For clinics, sourcing through unauthorized channels introduces risks related to product handling, storage, and authenticity verification. It is essential to ensure suppliers provide full traceability for every batch. Guides like Verifying Genuine Elasty Plus 1CC: An Anti-Counterfeit Guide offer insights into verifying product authenticity for other popular HA fillers.

To ensure compliance and product integrity, clinics should demand comprehensive documentation from their wholesale suppliers for Restylane Refyne. This includes:

• Certificates of Authenticity (COA): Proof that the product originated from Galderma.
• Batch and Lot Numbers: Essential for traceability and recall procedures.
• Cold Chain Documentation: Verification of appropriate storage and transportation conditions, crucial for product stability.
• Customs Declarations and Import Licenses: Demonstrating legal importation into your jurisdiction.
• Product Registration Certificates: Evidence of local market approval where applicable. Understanding how to verify genuine products extends to other brands; for example, referring to How to Verify Genuine Neuramis: An Anti-Counterfeit Guide can inform your verification protocols for various injectables.

When sourcing Restylane Refyne for your clinic, consider not only regulatory compliance but also the commercial terms. Wholesale pricing often reflects volume commitments. Illustrative wholesale pricing for Restylane Refyne may commence around $97.0 per unit. Typical volume tiers can offer progressive reductions: for example, orders of 11 units may see a 4% reduction, 21 units a 5% reduction, 31 units a 6% reduction, and orders of 51 units or more potentially an 8% reduction. These structures allow professionals to optimize their inventory costs while maintaining a consistent supply of product. Other HA fillers like LEXYAL or D.Fill Medium may offer similar tiered pricing models, which are standard in B2B distribution.